Biotech Firm Goes Crypto, Plans $520M BNB Push
Windtree Therapeutics is a publicly listed biotech company (WINT) that develops treatments for acute cardiovascular and pulmonary conditions.
It is now planning to raise up to $520M through equity agreements to build a BNB reserve, directing 99% of the funds toward acquiring BNB as part of its treasury diversification strategy, with nearly $700M committed in total.
Pending shareholder approval to increase authorized shares, Windtree has also partnered with Kraken to manage its treasury for secure custody and liquidity.
Source: BeInCrypto
10.73K
24
The content on this page is provided by third parties. Unless otherwise stated, OKX is not the author of the cited article(s) and does not claim any copyright in the materials. The content is provided for informational purposes only and does not represent the views of OKX. It is not intended to be an endorsement of any kind and should not be considered investment advice or a solicitation to buy or sell digital assets. To the extent generative AI is utilized to provide summaries or other information, such AI generated content may be inaccurate or inconsistent. Please read the linked article for more details and information. OKX is not responsible for content hosted on third party sites. Digital asset holdings, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition.